Novel System Snags FDA Approval for Severe Peripheral Arterial Disease
(MedPage Today) -- The FDA approved the LimFlow system designed to stave off amputation for people with chronic limb-threatening ischemia (CLTI) and no treatment alternatives, device maker LimFlow SA announced Tuesday. This puts the first device...
Source: MedPage Today Public Health - September 12, 2023 Category: American Health Source Type: news

Finding Power in My Panic Attacks
Trouble started in the form of rivulets of sweat dampening the waistband of my underwear. It was a bluebird afternoon in Phoenix in December of 2020, mid 60s, desert dry, and my heart was jackhammering against my ribcage. Breathing felt like I was sucking air through a stir straw. A small ABC News crew was arrayed before me, ready to broadcast the report I’d written that day, but with my vision narrowed to a needle’s eye, I could barely see them. I tried to swallow away the sandiness in my mouth but realized I’d forgotten how. [time-brightcove not-tgx=”true”] “I can’t swallow!...
Source: TIME: Health - September 12, 2023 Category: Consumer Health News Authors: Matt Gutman Tags: Uncategorized freelance Source Type: news

UBMD Emergency Medicine program expands into New Jersey
UBMD Emergency Medicine's addiction treatment program launched in 2017 and is likely to expand into other states by year-end.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 12, 2023 Category: Pharmaceuticals Authors: Tracey Drury Source Type: news

Turmeric may be as good for treating indigestion as drug to curb excess stomach acid
A natural compound found in the culinary spice turmeric may be as effective as omeprazole - a drug used to curb excess stomach acid—for treating indigestion symptoms, suggests the first study of its kind, published online in the journal BMJ Evidence-Based Medicine. Turmeric is derived from the root of the Curcuma longa plant. It contains a naturally active compound called curcumin thought to have anti-inflammatory and antimicrobial properties, and has long been used as a medicinal remedy, including for the treatment of indigestion, in South East Asia.
Source: World Pharma News - September 12, 2023 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

FAPI-PET/CT may improve treatment of cancer patients
Gallium-68 (Ga-68) FAPI-PET/CT imaging -- a highly accurate experimental approac...Read more on AuntMinnie.comRelated Reading: FAPI-PET shows promise for diagnosing lung cancer FAPI-PET predicts treatment response in liver cancer patients FAPI-PET shows promise visualizing cardiomyopathies FAPI-PET shows promise in patients with RA FAPI-PET detects rare tumor in COVID-19 patient
Source: AuntMinnie.com Headlines - September 12, 2023 Category: Radiology Source Type: news

PET imaging predicts long-term outcomes in Parkinson's disease
PET brain imaging in individuals with early Parkinson's disease can show whic...Read more on AuntMinnie.comRelated Reading: PET shows promise in diagnosing atypical parkinsonism Ultrasound ablation improves motor function in Parkinson's disease patients MRI, PET boost central nervous system disease treatment discovery Brain PET algorithm shows promise in diagnosing Parkinson's disease More white-matter hyperintensity equals greater parkinsonism risk
Source: AuntMinnie.com Headlines - September 12, 2023 Category: Radiology Source Type: news

The temporal dependencies between social, emotional and physical health factors in young people receiving mental healthcare: a dynamic Bayesian network analysis - Iorfino F, Varidel M, Marchant R, Cripps S, Crouse J, Prodan A, Oliveria R, Carpenter JS, Hermens DF, Guastella A, Scott E, Shah J, Merikangas K, Scott J, Hickie IB.
AIMS: The needs of young people attending mental healthcare can be complex and often span multiple domains (e.g., social, emotional and physical health factors). These factors often complicate treatment approaches and contribute to poorer outcomes in youth...
Source: SafetyLit - September 12, 2023 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

' New Dawn ' for Aldosterone as Drug Target in Hypertension? ' New Dawn ' for Aldosterone as Drug Target in Hypertension?
Treatment with the aldosterone synthase inhibitor lorundrostat significantly decreased automated office systolic blood pressure in adults with uncontrolled hypertension in the phase 2 TARGET-HTN trial.Medscape Medical News
Source: Medscape Cardiology Headlines - September 12, 2023 Category: Cardiology Tags: Cardiology News Source Type: news

AI in Healthcare: A Revolution in Diagnosis and Treatment
Hey, HealthTech Enthusiasts! Are you ready to dive into one of the most groundbreaking applications of AI and Data Science? That’s right, we’re talking about the Healthcare sector today! Grab your stethoscope and lab coat because we’re exploring how AI revolutionizes diagnosis and treatment. Trust…#healthcare #ibm
Source: Reuters: Health - September 12, 2023 Category: Consumer Health News Source Type: news

Patients With Narcolepsy Face Mood and Pain Disorders
(MedPage Today) -- NASHVILLE, Tenn. -- People with narcolepsy frequently had mood and pain comorbidities that complicated diagnosis and treatment plans, observational data showed. In a propensity-matched cohort analysis of more than 4,000 individuals...
Source: MedPage Today Psychiatry - September 12, 2023 Category: Psychiatry Source Type: news

Celiac disease: Diagnosis & treatment
Source: MayoClinic.com Full Feed - September 12, 2023 Category: Consumer Health News Source Type: news

Day One Announces Updated FIREFLY-1 Data for Tovorafenib and Completion of Rolling NDA Submission to FDA for Relapsed or Progressive Pediatric Low-Grade Glioma (pLGG)
Overall response rate (ORR) greater than 50% across three assessment criteria Median duration of tovorafenib treatment of 15.8 months as of June 5, 2023, with 66% of patients remaining on treatment FDA filing decision expected by...
Source: Drugs.com - New Drug Applications - September 11, 2023 Category: Drugs & Pharmacology Source Type: news

One in three Brits don't believe they can access NHS GP, ambulance or hospital treatment in a 'timely way', damning survey reveals
Healthwatch England described the results as 'worrying' and warned health leaders must act to ensure these 'negative perceptions' do not put patients off seeking help.
Source: the Mail online | Health - September 11, 2023 Category: Consumer Health News Source Type: news

Verona Pharma Announces the US FDA has Accepted the New Drug Application Filing for Ensifentrine for the Maintenance Treatment of COPD
PDUFA Target Action Date of June 26, 2024 Ensifentrine, if approved, is expected to be the first novel mechanism available for the maintenance treatment of COPD in more than a decade LONDON and RALEIGH, N.C., Sept. 11, 2023 (GLOBE NEWSWIRE) --...
Source: Drugs.com - New Drug Applications - September 11, 2023 Category: Drugs & Pharmacology Source Type: news

DHS Awards Funding to Law Enforcement Agencies Working to Address the Opioid Epidemic
DHS Awards Funding to Law Enforcement Agencies Working to Address the Opioid Epidemic The Wisconsin Department of Health Services (DHS) has awarded grants to six law enforcement agencies to support their work addressing the opioid epidemic in our state. The Buffalo, Columbia, Eau Claire, Marathon, and Sawyer County Sheriff ’s Offices, and the Village of Cottage Grove Police Department will receive funds to support community drug disposal programs, programs that keep people with an opioid use disorder out of jail, medication-assisted treatment for opioid use disorder education and...(see release)Elizabeth.GoodsittSeptember 11, 2023
Source: Wisconsin DHFS Press Releases - September 11, 2023 Category: Hospital Management Authors: Elizabeth.Goodsitt Source Type: news

Pages: 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20